20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghazadeh-Habashi, A; Asghar, W; Jamali, F | 1 |
| Ahmed, SA; Al-Lawati, H; Jamali, F | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Adjuvant Arthritis
| Article | Year |
|---|---|
Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Experimental; Celecoxib; Cytochrome P-450 Enzyme System; Heart; Hydroxyeicosatetraenoic Acids; Inflammation; Kidney; Lactones; Male; Meloxicam; Rats; Rats, Sprague-Dawley; Sulfones; Thiazines; Thiazoles | 2018 |
Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Experimental; Cardiovascular Diseases; Diclofenac; Hydroxyeicosatetraenoic Acids; Male; Rats; Rats, Sprague-Dawley; Risk Factors | 2019 |